- FoI Number
- 2024-604
- Subject
- Human Albumin
- Date Received
- 10/01/2025
- Request and Response
-
The amount of human albumin in grams purchased by the Board in 2023 and 2024 (the entire calendar year) total for both strengths purchased = 1265g. Note quantities purchased and quantities issued over a calendar year are not the same, see table below.
- Broken down by manufacturer (Bio Products Laboratory, Grifols, Biotest, CSL Behring, Octapharma, Takeda
Only purchased CSL Behring brand as per contract
- By concentration (4.5%, 5%, 20%) and
See below
- By service ordering albumin (ICU, Liver unit, etc.)
See below
Total vials issued to clinical areas
Vials purchased
20% solution, 100ml bottle, CSL Behring manufacturer only (Alburex)
2023
Medical inpatient ward: 18
A&E: 2
19
2024
Medical inpatient ward: 21
33
5% solution, 500ml bottle, CSL Behring manufacturer only (Alburex)
2023
0
0
2024
Medical inpatient ward: 3
A&E: 1
9
